Among these genes, elevated ITGAM expression was found to be associated with improved NSCLC patient DFS (HR = 0.73, 95% CI: 1.26–1.81, P = 0.045) (Fig 4). This evidence concerns the gene ITGAM and non-small cell lung carcinoma.